These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36481388)

  • 1. Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1.
    Hashizume M; Takashima A; Ono C; Okamoto T; Iwasaki M
    Antiviral Res; 2023 Jan; 209():105481. PubMed ID: 36481388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
    Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
    J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry.
    Perez-Miller S; Patek M; Moutal A; Duran P; Cabel CR; Thorne CA; Campos SK; Khanna R
    ACS Chem Neurosci; 2021 Apr; 12(8):1299-1312. PubMed ID: 33787218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain-2 mediates SARS-CoV-2 entry via regulating ACE2 levels.
    Zeng Q; Antia A; Casorla-Perez LA; Puray-Chavez M; Kutluay SB; Ciorba MA; Ding S
    mBio; 2024 Mar; 15(3):e0228723. PubMed ID: 38349185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
    Xiang Y; Wang M; Chen H; Chen L
    Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repositioning of histamine H
    Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
    Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
    Verma D; Church TM; Swaminathan S
    J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein.
    Liang T; Xiao S; Wu Z; Lv X; Liu S; Hu M; Li G; Li P; Ma X
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37632009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein.
    Manangeeswaran M; Ireland DDC; Thacker SG; Lee HN; Kelley-Baker L; Lewkowicz AP; Rothlauf PW; Cornejo Pontelli M; Bloyet LM; Eckhaus MA; Mendoza MI; Whelan S; Verthelyi D
    Front Immunol; 2022; 13():919815. PubMed ID: 35967447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection.
    Chapoval SP; Keegan AD
    Mol Med; 2021 Dec; 27(1):162. PubMed ID: 34961486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical activation of spike fosters SARS-CoV-2 viral infection.
    Hu W; Zhang Y; Fei P; Zhang T; Yao D; Gao Y; Liu J; Chen H; Lu Q; Mudianto T; Zhang X; Xiao C; Ye Y; Sun Q; Zhang J; Xie Q; Wang PH; Wang J; Li Z; Lou J; Chen W
    Cell Res; 2021 Oct; 31(10):1047-1060. PubMed ID: 34465913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
    Lu J; Hou Y; Ge S; Wang X; Wang J; Hu T; Lv Y; He H; Wang C
    Life Sci; 2021 Feb; 266():118889. PubMed ID: 33310043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade.
    Han S; Zhao G; Wei Z; Chen Y; Zhao J; He Y; He YJ; Gao J; Chen S; Du C; Wang T; Sun W; Huang Y; Wang C; Wang J
    Peptides; 2021 Nov; 145():170638. PubMed ID: 34419496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
    Cantuti-Castelvetri L; Ojha R; Pedro LD; Djannatian M; Franz J; Kuivanen S; van der Meer F; Kallio K; Kaya T; Anastasina M; Smura T; Levanov L; Szirovicza L; Tobi A; Kallio-Kokko H; Österlund P; Joensuu M; Meunier FA; Butcher SJ; Winkler MS; Mollenhauer B; Helenius A; Gokce O; Teesalu T; Hepojoki J; Vapalahti O; Stadelmann C; Balistreri G; Simons M
    Science; 2020 Nov; 370(6518):856-860. PubMed ID: 33082293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces.
    Lapaillerie D; Charlier C; Guyonnet-Dupérat V; Murigneux E; Fernandes HS; Martins FG; Magalhães RP; Vieira TF; Richetta C; Subra F; Lebourgeois S; Charpentier C; Descamps D; Visseaux B; Weigel P; Favereaux A; Beauvineau C; Buron F; Teulade-Fichou MP; Routier S; Gallois-Montbrun S; Meertens L; Delelis O; Sousa SF; Parissi V
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0008322. PubMed ID: 35861550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation.
    Yu S; Zheng X; Zhou B; Li J; Chen M; Deng R; Wong G; Lavillette D; Meng G
    Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34930824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.